CSIMarket
 
Melinta Therapeutics, Inc.  (CEMP)
Other Ticker:  
 
 

Melinta Therapeutics's Suppliers Performance

CEMP's Supply Chain

 
CEMP Costs vs Sales of Suppliers Growth Melinta Therapeutics's cost of sales deteriorated by -38.68 % year on year, relative to one quarter ago cost of sales fell by -4.93 % in Q3.

More on CEMP Suppliers




Melinta Therapeutics's cost of sales deteriorated by -38.68 % year on year, compare to one quarter ago cost of sales fell by -4.93 % in Q3.

More on CEMP Suppliers



  News about Melinta Therapeutics, Inc. Contracts



Melinta Therapeutics's Comment on Supply Chain









CEMP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Melinta Therapeutics, Inc. 31.65 81.40 -320.21 253
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com